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INTRODUCTION 
Human Immunodeficiency Virus (HIV) was identified 
as the causative agent of Acquired Immunodeficiency 
Syndrome in 1983 [1]. HIV infection is a risk factor for 
a variety of endocrine problems [2] and throughout the 
world, heterosexual transmission is still the most com-
mon route of spreading HIV-1 infection [3]. Regretta-
bly, the HIV widespread lingers to be a load worldwide 
and offers grave public health glitches in emerging 
countries particularly in Nigeria [4-6].  
In 2013, UNAIDS estimated that globally 35.3million 
people were living with HIV-1 in the world [7]. Similar-
ly, Nigeria is estimated to have the second highest num-
ber of persons living with HIV/AIDS after South Africa 
[8, 9].  
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As HIV continues to survive and replicate within its 
human host, it eventually weakens the immune system 
of the host, leaving the infected individual susceptible to 
opportunistic infections and neoplasms which have been 
observed to have affected the endocrine system in pa-
tients with AIDS [10]. HIV infected persons have an 
increased risk of developing endocrine abnormalities 
and many HIV infected persons have been reported to 
have elevated basal cortisol levels [11]. However, a 
number of these abnormalities occur as a result of non-
specific endocrine responses to stress, infection and 
malnutrition [12].  
The hypothalamic pituitary adrenal (HPA) axis and the 
systemic sympathetic/adrenomedullary system are the 
peripheral branches of the stress system, whose main 
function is to maintain basal and stress-related homeo-
stasis [13]. Generally, viral infections such as HIV/
AIDS are physiologically stressful. Therefore, this study 
assessed the body mass index, blood pressure and serum 
cortisol levels as stress index in symptomatic HIV/
AIDS male subjects on antiretroviral therapy negative to 
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malaria parasite in Nnewi, Anambra State, Nigeria 
Aim: The study designed to evaluate the serum hormo-
nal levels in malaria uninfected symptomatic HIV 
(Stage II) male subjects on antiretroviral therapy in 
Nnewi, South Eastern Nigeria.  
MATERIALS  AND METHODOLOGY 
Study design: This is a case-controlled study 
Ethics approval: The subjects were given informed 
consent, while the study design was approved by the 
ethical committee. 
Research place: Nnamdi Azikiwe University Teaching 
Hospital, Nnewi, Nigeria. 
Sample size: A total of 274 adult male participants 
Inclusion criteria: aged between 18 and 60 (42 ±13) 
years were randomly recruited at the Voluntary Coun-
seling and Testing (VCT) Centre in Nnamdi Azikiwe 
University Teaching Hospital (NAUTH), Nnewi, Nige-
ria.  
Grouping: Based on World Health Organization 
(WHO) criteria for staging HIV, the participants were 
grouped as follows: symptomatic HIV (stage 11) infect-
ed male participants on ART (n=69). Lamivudine, 150 
mg twice daily, Stavudine, 40mg twice daily and Nevi-
rapine, 200 mg twice daily: this was administered to the 
symptomatic HIV stage 11 subjects on ART. Sympto-
matic HIV subjects not on ART (n= 69), Asymptomatic 
HIV positive subjects (n= 68) and HIV seronegative 
subjects (n= 68).  
Methodology:  
5 ml of blood sample were collected from each of the 
participant in the groups. The serum samples were 
stored at -20°C until analyzed. The participants were 
screened for HIV infection using Immunoassay and 
Immunochromatographic method. The serum was used 
for the estimation of cortisol level.  
Detection of antibodies to HIV-1 and HIV-2in hu-
man plasma: Two different methods were used, name-
ly, Abbott determine TM HIV -1 and HIV-2 kit, which 
is an in-vitro visually read immunoassay (Abbott Japan 
Co.Ltd. Tokyo, Japan) and HIV-1 and 2 STAT-PAK 
Assay kit, which is an Immunochromatographic test for 
the quantitative detection of antibodies to HIV-1 and 
HIV-2 in Human plasma (CHEMBIO Diagnostic sys-
tem, Inc, New York, USA). For the Abbott determine 
TM HIV -1 and HIV-2 kit, the procedure described by 
the manufacturer were used for the analysis. Also, for 
the Immunochromatographic method for HIV-1 and 
HIV-2, the procedure described by the manufacturer 
was used for the analysis.  
Estimation of Cortisol: Serum Cortisol was estimated 
by Enzyme Linked Immunosorbent assay (ELISA) 
method as described by DRG Diagnostics [14].  
Measurement of body mass index and blood pres-
sure readings: Body mass index (BMI) was calculated 
by using the method as described by [15], whereas, the 
blood pressure readings were based on the method ac-
cording to Paynter and Parkin, [16].  
Statistical analysis: The data obtained was statistically 
analyzed using Statistical Package for Social Sciences 
(SPSS) version 16.0. One of way analysis of variance 
(ANOVA) and students’ t-test were used to compare 
means. The results were expressed as mean ±SD and 
confidence limits was chosen at 95% (P <0.05). P <0.05 
was considered statistically significant while P>0.05 
was insignificant.  
RESULTS   
The result of analysis of variance showed that the mean 
BMI (Kg/m2) and serum cortisol concentration were 
significantly different amongst the group (F=20.958 and 
22.39) respectively (p<0.05), whereas, the mean SBP 
(mmHg) and DBP (mmHg) did not differ significantly 
amongst the group (F=1.774 and 1.999) respectively 
(p>0.05).  
The result of independent student’s t-test showed that 
the mean BMI (23.68±3.68 Vs 19.61±3.40) as well as 
serum cortisol concentration (139.78±63.24 Vs 
250.56±135.24) were significantly lower in HIV/AIDS 
seropositive participants on ART compared with HIV/
AIDS seropositive participants not on ART (p=0.000) 
respectively, whereas the mean ± SD of SBP and DBP 
did not differ significantly in HIV/AIDS participants on 
ART compared with values obtained in HIV/AIDS par-
ticipants not on ART (p>0.05).  
The mean± SD of BMI , SBP, DBP and serum cortisol 
level were similar in HIV/AIDS seropositive partici-
pants on ART in comparison with the values obtained in 
Asymptomatic HIV-positive subjects (p>0.05 in each 
case). 
Also, the mean± SD of BMI , SBP, DBP and serum 
cortisol level did not differ significantly in HIV/AIDS 
seropositive participants on ART than in the control 
group (p>0.05 in each case). 
However, the mean± SD of BMI in the HIV/AIDS sero-
positive participants not on ART was significantly low-
er compared with the values obtained in Asymptomatic 
HIV-positive subjects (p=0.000), while the mean±SD of 
serum cortisol concentration was significantly higher in 
HIV/AIDS seropositive participants not on ART than 
Asymptomatic HIV-positive subjects (250.56±135.24 
Vs 141.81±77.08; p=0.000). 
Furthermore, the mean±SD of SBP and DBP were not 
significantly different in HIV/AIDS seropositive partici-
pants not on ART compared with Asymptomatic HIV-
positive subjects (p>0.05 in each case). Also, the mean 
± SD of BMI was significantly lower in the HIV/AIDS 
seropositive participants not on ART compared with 
control (19.61±3.40 Vs22.66±3.10; p=0.000), whereas 
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the mean± SD of serum cortisol level was significantly 
higher in HIV/AIDS seropositive participants not on 
ART than in the control (250.56±135.24 Vs 
130.02±68.20; p=0.000).  
Again, the mean± SD of BMI, SBP, DBP and serum 
cortisol level in Asymptomatic HIV-positive subjects 
were similar with the values obtained in the control 
(p>0.05 in each case) respectively. 
DISCUSSION 
The introduction of anti-retroviral (AVR) drugs has 
significantly reduced both morbidity and mortality at-
tributable to HIV infection [17].  
The present study revealed a significant elevation in the 
mean body mass index (BMI) of HIV/AIDS seroposi-
tive participants on ART compared with HIV/AIDS 
seropositive subjects not on ART (23.68±3.63 Vs 
19.61±3.40; p=0.000). This increase may be as a result 
of the beneficial and recovering potential of the an-
tiretroviral therapy on the subjects used in this study. 
Again, it is suggestive of a reduction of wasting disease 
among the subjects on ART. Our finding is in line with 
the previous studies which had earlier documented var-
ied degree of weight gain among HIV/AIDS subjects on 
ART [18-22]. However, based on the WHO classifica-
tion of BMI levels given as follows [22]: underweight ≤ 
18.5 kg/m2, normal weight =18.5 - 24.9 kg/m2, over-
weight = 25.0 - 29.9 kg/m2, obesity class I = 30.0 - 34.9 
kg/m2, obesity class II = 35.0 -39.9 kg/m2, obesity class 
III ≥ 40.0 kg/m2, our participants on ART had an in-
creased BMI which was still within the normal range 
(18.5 - 24.9 kg/m2).  
However, no significant statistical difference was ob-
served in the present study between the mean body mass 
index of the HIV/AIDS seropositive participants on 
ART compared with the control subjects (p>0.05). This 
finding implies that the BMI of the HIV/AIDS seroposi-
tive subjects on ART are similar to that obtainable in the 
general healthy population; indicating an improving 
health status among the HIV/AIDS subjects on ART. 
In this study, the mean Systolic blood pressure (SBP) 
and Diastolic blood pressure (DBP) did not differ signif-
icantly when compared between HIV/AIDS seropositive 
participants on ART and those not on ART (P>0.05). 
Similarly, no significant statistical differences were ob-
served in the mean SBP and DBP of HIV/AIDS sero-
positive subjects on ART in comparison with the control 
group (p>0.05). This is in consonance with the report of 
Dimala et al. [23].  
Interestingly, the mean cortisol level was significantly 
decreased in HIV/AIDS seropositive participants on 
ART than in HIV/AIDS seropositive participants not on 
ART (139.78±63.24 Vs 250.56±135.24; p=0.000). This 
is in contrast with the report of Rateni et al. who report-
ed similar levels of cortisol in HIV patients before and 
after ART [24]. This decrease may be attributed to the 
effect of ART on the adrenal gland. Also, it may imply 
an increased survival and reduced occurrence of oppor-
tunistic diseases after the use of ART [25], as viral in-
fections are generally physiologically stressful. 
Also, the mean cortisol level was observed to be signifi-
cantly elevated in HIV/AIDS subjects not on ART than 
in control subjects (p=0.000). This finding is in keeping 
with the report of previous studies [26-28]. This con-
firms the fact that adrenal gland dysfunction is the most 
common and most serious endocrine disorder affecting 
HIV/AIDS patients [29]. Again, it is indicative of a high 
degree of stress experience by HIV/AIDS patients who 
are not receiving Anti-retroviral therapy. Furthermore, a 
number of pathogenic mechanisms have been postulated 
Variables BMI (Kg/m2) SBP (mmHg) DBP (mmHg) Cortisol (ng/ml) 
HIV/AIDS on ART (A) 23.68±3.63 117.39±11.02 73.55±7.02 139.78±63.24 
HIV/AIDS not on ART (B)  19.61±3.40 119.71±13.50 73.19±8.49 250.56±135.24 
Asymptomatic HIV positive sub-
ject (C)  
23.60±3.67 112.35±12.35 76.05±7.15 141.81±77.08 
Control (D)  22.66±3.10 119.41±13.48 77.79±9.28 130.02±68.20 
P-value 0.000 0.152 0.144 0.000 
F-value 20.958 1.774 1.999 22.39 
A V B 0.000 0.688 0.176 0.000 
A V C 0.999 0.069 1.000 0.488 
A V D 0.290 0.773 0.093 0.999 
B V C 0.000 0.631 0.152 0.000 
B V D 0.000 0.999 0.984 0.000 
C V D 0.374 0.544 0.246 0.936 
Table 1: Assessment of BMI, SBP, DBP and Serum cortisol in malaria negative HIV adult male subjects 
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explaining the underlying mechanism behind the hyper-
cortisolemia found in untreated HIV-positive persons. 
First, the shift of steroid metabolism from aldosterone, 
DHEA AND 17-deoxysteroids to cortisol may be indic-
ative of an adaptive response to stress [30-33]. Second-
ly, it could be due to the cortisol binding globulin of 
HIV-infected patients that shows a higher number of 
binding sites compared with controls [34]. Again, the 
increased cortisol synthesis in the absence of an increase 
in corticotropin suggests that some non-pituitary factors 
derived from infected immune cell such as interleukin 
(IL)-1β and IL-6 [27, 35, 36] might directly stimulate 
the adrenal cortex.  
However, the mean cortisol level did not differ signifi-
cantly between HIV/AIDS seropositive participants on 
ART and the controls (p=0.999). This may be sugges-
tive of the ameliorative effect of ART on HIV/AIDS 
disease, thus reducing the stress level in the HIV/AIDS 
and restoring them similarly to that comparable with 
healthy population. 
CONCLUSION 
This study revealed a decreased stress index in HIV/
AIDS subjects on ART with hypercortisolism and lower 
BMI in symptomatic HIV participants not on ART. Al-
so, the mean SBP and DBP of subjects remained same.  
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